嚢胞性線維症(CF症)治療薬の世界市場2016-2020...市場調査レポートについてご紹介

【英文タイトル】Global Cystic Fibrosis Therapeutics Market 2016-2020

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Disease overview
• Understanding the disease
• Pathophysiology
• Diagnosis
• Manifestations of cystic fibrosis

PART 06: Pipeline analysis

PART 07: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 08: Market segmentation by drug class
• CFTR modulators
• Mucolytics
• PERT
• Anti-infectives
• Bronchodilators

PART 09: Market segmentation by molecule type
• Small molecules
• Biologics

PART 10: Geographical segmentation
• Global cystic fibrosis therapeutics market by geography
• Cystic fibrosis therapeutics market in Americas
• Cystic fibrosis therapeutics market in EMEA
• Cystic fibrosis therapeutics market in APAC

PART 11: Key leading countries
• The US
• The UK
• France
• Canada
• Italy

PART 12: Market drivers
• Special regulatory designations for drugs
• Increased uptake of CFTR modulators
• Improvement in diagnostic technologies

PART 13: Impact of drivers

PART 14: Market challenges
• Discontinuation of drugs from development
• Difficulty in developing drugs due to rarity of disease

PART 15: Impact of drivers and challenges

PART 16: Market trends
• Co-pay and assistance programs by vendors
• Strategic collaborations
• Advances in technology for drug development and delivery

PART 17: Vendor landscape
• Competitive scenario
• Other prominent vendors

PART 18: Key vendor analysis
• Vertex Pharmaceuticals
• F. Hoffmann-La Roche
• AbbVie
• Gilead Sciences
• Novartis

PART 19: Appendix
• List of abbreviations

PART 20: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Key buying criteria for global cystic fibrosis therapeutics market 2015
Exhibit 03: Key customer segments of cystic fibrosis therapeutics market
Exhibit 04: Snapshot of cystic fibrosis
Exhibit 05: Defects caused by CFTR mutation
Exhibit 06: Diagnosis of cystic fibrosis
Exhibit 07: Pipeline portfolio: Global cystic fibrosis therapeutics market
Exhibit 08: Global cystic fibrosis therapeutics market: Market overview 2015
Exhibit 09: Global cystic fibrosis therapeutics market snapshot: Developed and emerging markets 2015
Exhibit 10: Global cystic fibrosis therapeutics market 2015-2020 ($ billions)
Exhibit 11: Opportunity analysis: Global cystic fibrosis therapeutics market
Exhibit 12: Impact of factors affecting the market 2015 and 2020
Exhibit 13: Five forces analysis
Exhibit 14: Global cystic fibrosis therapeutics by drug class 2015
Exhibit 15: Global cystic fibrosis therapeutics market by molecule type 2015
Exhibit 16: Global cystic fibrosis therapeutics market by geography 2015-2020
Exhibit 17: Percentage share of global cystic fibrosis therapeutics market by geography 2015 and 2020
Exhibit 18: Global cystic fibrosis therapeutics market by geography 2015-2020 ($ billions)
Exhibit 19: Global share of cystic fibrosis therapeutics market by geography 2015
Exhibit 20: Global cystic fibrosis therapeutics market by region: Market growth lifecycle analysis 2015
Exhibit 21: Global cystic fibrosis therapeutics market: Country analysis based on revenue and growth rate
Exhibit 22: Opportunity analysis: Cystic fibrosis therapeutics market in Americas
Exhibit 23: Cystic fibrosis therapeutics market in Americas 2015-2020 ($ billions)
Exhibit 24: Opportunity analysis: Cystic fibrosis therapeutics market in EMEA
Exhibit 25: Cystic fibrosis therapeutics market in EMEA 2015-2020 ($ billions)
Exhibit 26: Opportunity analysis: Cystic fibrosis therapeutics market in APAC
Exhibit 27: Cystic fibrosis therapeutics market in APAC 2015-2020 ($ millions)
Exhibit 28: Key leading countries for cystic fibrosis therapeutics market
Exhibit 29: Impact of drivers and challenges on global cystic fibrosis therapeutics market
Exhibit 30: Few drugs with breakthrough therapy designation for cystic fibrosis
Exhibit 31: Drugs with orphan drug designation for cystic fibrosis
Exhibit 32: Impact of drivers
Exhibit 33: Few cystic fibrosis therapeutics discontinued from development
Exhibit 34: Impact of drivers and challenges
Exhibit 35: Global cystic fibrosis therapeutics market: Impact assessment of key trends
Exhibit 36: Few cystic fibrosis therapeutics with patient assistance programs
Exhibit 37: Key vendors ranking 2015
Exhibit 38: Geographical presence of key vendors 2015
Exhibit 39: Competitive scenario of market vendors 2015-2020
Exhibit 40: Vertex Pharmaceuticals: Profile
Exhibit 41: Vertex Pharmaceuticals: Strength analysis
Exhibit 42: Vertex Pharmaceuticals: Growth strategy matrix
Exhibit 43: Vertex Pharmaceuticals: Opportunity assessment
Exhibit 44: Vertex Pharmaceuticals: Revenue of ORKAMBI and Kalydeco 2015 ($ millions)
Exhibit 45: F. Hoffmann-La Roche: Profile
Exhibit 46: F. Hoffmann-La Roche: Strength analysis
Exhibit 47: F. Hoffmann-La Roche: Growth strategy matrix
Exhibit 48: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 49: F. Hoffmann-La Roche: YoY growth and revenue generated from sales of Pulmozyme 2013-2015 ($ millions)
Exhibit 50: AbbVie: Profile
Exhibit 51: AbbVie: Strength analysis
Exhibit 52: AbbVie: Growth strategy matrix
Exhibit 53: AbbVie: Opportunity assessment
Exhibit 54: AbbVie: YoY growth and revenue of Creon 2013-2015 ($ millions)
Exhibit 55: Gilead Sciences: Profile
Exhibit 56: Gilead Sciences: Strength analysis
Exhibit 57: Gilead Sciences: Growth strategy matrix
Exhibit 58: Gilead Sciences: Opportunity assessment
Exhibit 59: Novartis: Profile
Exhibit 60: Novartis: Strength analysis
Exhibit 61: Novartis: Growth strategy matrix
Exhibit 62: Novartis: Opportunity assessment


【レポート販売概要】

■ タイトル:嚢胞性線維症(CF症)治療薬の世界市場2016-2020
■ 英文:Global Cystic Fibrosis Therapeutics Market 2016-2020
■ 発行日:2016年10月5日
■ 調査会社:Technavio
■ 商品コード:IRTNTR10588
■ 調査対象地域:グローバル
  • 頭蓋顎顔面固定(CMF)デバイスの世界市場2015-2019
    About Craniomaxillofacial devices Craniomaxillofacial traumas caused by sports injuries and traffic accidents can result in frontal bone fracture, orbital fracture, maxillary fracture, and mandibular fracture. CMF devices are used to repair and reconstruct the cranial and facial fractures. These devices are also used to reconstruct genetic defects such as cleft palate, Down syndrome, and Treacher …
  • 世界の可変周波機器市場
    Growing demand for electrical efficiency and increasing investment in modernization of infrastructure will drive the global VFD (variable frequency drives)/VSD (variable speed drives)/ASD (adjustable speed drives)/inverters market to $18,854 million by 2017, with a CAGR of 8.7% from 2012 to 2017. Asia-Pacific, with its thriving economies and rapidly expanding manufacturing bases, is expected to ex …
  • 治療薬剤モニタリングの世界市場2017-2021
    ABSTRACTAbout Therapeutic Drug Monitoring Therapeutic drug monitoring is a branch of clinical pharmacology and clinical chemistry that specializes in the measurement of drug concentration in blood. It is mainly performed on the drugs with a narrow therapeutic window. Therapeutic drug monitoring aims at improving patient care by regulating the dose of drugs. It is based on a priori pharmacogenetic, …
  • 世界のトランスペアレントキャッシング(透過型キャッシュ)市場(2014-2018)
    About Transparent Caching Caching is the temporary storage of web content which helps in offloading the origin web or application server. Transparent caching is a solution that enables the service provider to offload a significant amount of content traffic by storing a cached copy of the popular content close to the edge of the network, which is delivered to the user directly from the edge of the …
  • インドのA4プリンター市場
    Technological advancements and reduction in the prices of Multi-Function printers (MFPs) have resulted in an increase in demand for laser printers over the inkjet based Single-Function printers (SFPs). Increasing penetration of internet in India has helped in the growth of digital content which in turn has attracted consumers towards reliable and cost efficient printing solutions.Growth in corpora …
  • ハイブリッドバスの世界市場:コンポーネント別(伝送装置、推進装置、動力伝導機構、その他)、産業別(高速道路輸送、公共輸送)、地域別予測
    Global Hybrid Bus Market to reach USD XXX billion by 2025. Global Hybrid Bus Market valued approximately USD XXX billion in 2016 is forecasted to grow with a healthy growth rate of more than XX% over the forecast period 2018-2025. The major factors speculated to augment the markets are growing eco-friendly initiatives pertaining to fuel emission, need for addressing consumers’ needs concerning fue …
  • 抗菌繊維の世界市場予測(~2024年)
    “Prevention of Hospital Acquired Infections through antimicrobial textile will drive the market”The global antimicrobial textile market is estimated to grow USD 9.5 billion in 2019 to USD 12.3 billion in 2024, at a CAGR of 5.4% during the forecast period. The use of antimicrobial textiles in the health care industry for the prevention of Hospital Acquired infections (HAIs) that not only cost lives …
  • SM Energy Company:石油・ガスの開発・生産動向及びコスト分析– Q4, 2012
    SM Energy Company Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2012 Summary SM Energy Company Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key …
  • 世界のカルボン酸市場2015
    The Global Carboxylic Acids Industry Report 2015 is a professional and in-depth study on the current state of the Carboxylic Acids industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Carboxylic Acids market analysis is provided for the international markets including development trends, competitive la …
  • 世界のヘッドアップディスプレイ(HUD)市場動向(2012-2016)
    TechNavio's analysts forecast the Global Heads-up Display market to grow at a CAGR of 14.32 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing focus on improving safety and convenience for drivers/pilots of various vehicles. The Global Heads-up Display market has also been witnessing declining average selling prices (ASPs). However, the c …
  • 過酸化水素(HP)の世界市場予測
    Hydrogen peroxide 2014 World Market Outlook and Forecast is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about hydrogen peroxide market in the all-in-one report issued in a logical and easily accessible format. In addition to the analy …
  • バイオマスペレットの世界市場2015-2019
    About Biomass Pellets Biomass pellets are normally used as a heating fuel. The use of biomass pellets for heating and as a power source has increased enormously during recent years with many households and industrial facilities using pellet stoves or boilers over old-style wood-fired equipment. These pellets are generally derived from various sources including the timber industry, sawdust, sugarca …
  • 片頭痛(Migraine):企業動向
    PharmaPoint: Migraine - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Migraine - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Migraine Market. The report identifies and analyses the key companies shaping and driving the global Migraine market. The repo …
  • オフショア・デコミッショニング(廃止)の世界市場予測(~2025年)
    “The offshore decommissioning market is projected to grow at a CAGR of 5.05%, from 2017 to 2025.” The offshore decommissioning market is projected to reach USD 8.76 billion by 2025, growing at a CAGR of 5.05%, from 2017 to 2025. Offshore decommissioning is plugging the oil and gas wells which are matured and are non-productive. Maturing oil and gas fields and aging infrastructure in the North Sea …
  • 蓄膿(Empyema):世界の治験レビュー2014年下半期版
    Empyema Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Empyema Global Clinical Trials Review, H2, 2014" provides data on the Empyema clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Empyema. It includes an overview of the trial numbers and their recruitment status as per the site of trial conductio …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。